| Mutant KRAS promotes malignant pleural effusion formation T Agalioti, AD Giannou, AC Krontira, NI Kanellakis, D Kati, M Vreka, ... Nature Communications 8 (1), 15205, 2017 | 105 | 2017 |
| Club cells form lung adenocarcinomas and maintain the alveoli of adult mice Elife, 2019 | 58 | 2019 |
| Tobacco chemical-induced mouse lung adenocarcinoma cell lines pin the prolactin orthologue proliferin as a lung tumour promoter NI Kanellakis, AD Giannou, MAA Pepe, T Agalioti, DE Zazara, I Giopanou, ... Carcinogenesis 40 (11), 1352-1362, 2019 | 17 | 2019 |
| KRAS signaling in malignant pleural mesothelioma A Marazioti, AC Krontira, SJ Behrend, GA Giotopoulou, G Ntaliarda, ... EMBO Molecular Medicine 14 (2), e13631, 2022 | 16 | 2022 |
| Comprehensive clinical profiling of the Gauting locoregional lung adenocarcinoma donors LV Klotz, Y Courty, M Lindner, A Petit‐Courty, A Stowasser, I Koch, ... Cancer Medicine 8 (4), 1486-1499, 2019 | 16 | 2019 |
| Prognostic phenotypes of early-stage lung adenocarcinoma AS Lamort, JC Kaiser, MAA Pepe, I Lilis, G Ntaliarda, K Somogyi, ... European Respiratory Journal 60 (1), 2022 | 12 | 2022 |
| An in vivo inflammatory loop potentiates KRAS blockade KAM Arendt, G Ntaliarda, V Armenis, D Kati, C Henning, GA Giotopoulou, ... Biomedicines 10 (3), 592, 2022 | 5 | 2022 |
| Transcriptome signature of miRNA-26b KO mouse model suggests novel targets EPC van der Vorst, MAA Pepe, LJF Peters, M Haberbosch, Y Jansen, ... BMC genomic data 22, 1-14, 2021 | 4 | 2021 |
| Non-Oncogene Addiction of KRAS-Mutant Cancers to IL-1β via Versican and Mononuclear IKKβ M Spella, G Ntaliarda, G Skiadas, AS Lamort, M Vreka, A Marazioti, I Lilis, ... Cancers 15 (6), 1866, 2023 | 1 | 2023 |
| Transcriptome signatures of tobacco carcinogens hint the alteration of TAF6 as a specific feature in smokers lung cancer M Pepe, A Lamort, G Stathopoulos ERJ Open Research 6 (suppl 5), 2020 | 1 | 2020 |
| An in vivo inflammatory loop potentiates KRAS blockade KAM Arendt, G Ntaliarda, V Armenis, D Kati, C Henning, GA Giotopoulou, ... bioRxiv, 629139, 2019 | 1 | 2019 |
| Non-Oncogene Addiction of KRAS-Mutant Cancers to IL-1β via Versican and Mononuclear IKKβ. Cancers 2023, 15, 1866 M Spella, G Ntaliarda, G Skiadas, AS Lamort, M Vreka, A Marazioti, I Lilis, ... | | 2023 |
| LSC-2021-Mutational RNA signatures in environmentally-induced lung adenocarcinoma SJ Behrend, G Ntaliarda, AS Lamort, MAA Pepe, I Lilis, M Spella, ... European Respiratory Journal 58 (suppl 65), 2021 | | 2021 |
| Mapping of Kras mutations during chemical carcinogenesis SJ Behrend, M Spella, MAA Pepe, GA Giotopoulou, M Lianou, I Giopanou, ... European Respiratory Journal 58 (suppl 65), 2021 | | 2021 |
| Mapping carcinogen-specific patterns of mutation acquisition in the lungs M Pepe lmu, 2021 | | 2021 |
| Tumor-secreted versican co-opts myeloid IKKβ during metastasis M Spella, AS Lamort, M Vreka, A Marazioti, I Lilis, G Ntaliarda, G Skiadas, ... bioRxiv, 2021.05. 20.444963, 2021 | | 2021 |
| Causal RNA signatures in lung adenocarcinoma G Giotopoulou, M Pepe, S Behrend, G Ntaliarda, AS Lamort, I Lillis, ... European Respiratory Journal 56 (suppl 64), 2020 | | 2020 |
| LSC-2020-Transcriptome signatures of tobacco carcinogens hint the alteration of TAF6 as a specific feature in smokers lung cancer M Pepe, AS Lamort, G Stathopoulos European Respiratory Journal 56 (suppl 64), 2020 | | 2020 |
| Molecular hallmarks of smoking in the Gauting lung adenocarcinoma donors AS Lamort, MAA Pepe, SJ Behrend, I Lilis, G Ntaliarda, M Spella, ... European Respiratory Journal 56 (suppl 64), 2020 | | 2020 |
| Histologic hallmarks of smoking in the Gauting lung adenocarcinoma donors cohort A Lamort, M Pepe, G Ntaliarda, W Kujawa, I Lilis, M Spella, ... ERJ Open Research 6 (suppl 5), 2020 | | 2020 |
